Creating Brighter Days’ equine CBD product line is made using a nano-encapsulation process. This method has been used in the pharmaceutical industry for several decades to increase the bioavailability of hydrophobic (non-water soluble) ingredients, such as CBD oil.
The efficacy of CBD is determined not only by dosage, but by the bioavailability of the compound — or how much of the compound enters the bloodstream.
As an example, a CBD product with 40% bioavailability will have four times the effective dosage of a product with 10% bioavailability.
Nano-encapsulation encases microscopic amounts of CBD in a water-soluble shell, and thus is easily dissolved in water. This substantially increases CBD’s bioavailability in the body.
Sublingual absorption with nano technology allows CBD to directly enter the bloodstream, via blood vessels in the lining of the mouth.
The body digests and absorbs nano-encapsulated CBD as it would any food. But because the size of the emulsion is so small, CBD is made instantly available and is absorbed without relying on enzymes or digestive activity for breakdown.
This immediate absorption means CBD is able to reach and connect to endocannabiniod receptor sites prior to passing through the liver and being metabolized. And the effects of the product are less dependent on factors like diet or feeding schedule, generating more predictable, consistent results.
Compared to other products, nano-encapsulation also keeps CBD indefinitely stable, increasing the shelf life of the product.